BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 32930254)

  • 1. Dual polymeric prodrug co-assembled nanoparticles with precise ratiometric co-delivery of cisplatin and metformin for lung cancer chemoimmunotherapy.
    Yang T; Yu S; Liu L; Sun Y; Lan Y; Ma X; Zhu R; Li L; Hou Y; Liu Y
    Biomater Sci; 2020 Oct; 8(20):5698-5714. PubMed ID: 32930254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of IL-12 cytokine gene and cisplatin prodrug by a polymetformin-conjugated nanosystem for lung cancer chemo-gene treatment through chemotherapy sensitization and tumor microenvironment modulation.
    Sun Y; Yang J; Yang T; Li Y; Zhu R; Hou Y; Liu Y
    Acta Biomater; 2021 Jul; 128():447-461. PubMed ID: 33894351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer.
    Xiong Y; Zhao Y; Miao L; Lin CM; Huang L
    J Control Release; 2016 Dec; 244(Pt A):63-73. PubMed ID: 27840166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo-Gene Combination Therapy on Metastatic Breast Cancer.
    Sun Y; Liu L; Zhou L; Yu S; Lan Y; Liang Q; Liu J; Cao A; Liu Y
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45873-45890. PubMed ID: 32924511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine.
    Hong Y; Che S; Hui B; Wang X; Zhang X; Ma H
    Drug Des Devel Ther; 2020; 14():2263-2274. PubMed ID: 32606596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin.
    Tan S; Wang G
    Biomed Pharmacother; 2018 Jun; 102():55-63. PubMed ID: 29549729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer.
    Wang S; Gou J; Wang Y; Tan X; Zhao L; Jin X; Tang X
    Int J Nanomedicine; 2021; 16():2357-2372. PubMed ID: 33790554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
    Wang W; Xi M; Duan X; Wang Y; Kong F
    Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity.
    Yang F; Li A; Liu H; Zhang H
    Drug Des Devel Ther; 2018; 12():3321-3333. PubMed ID: 30323564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
    Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
    [No Abstract]   [Full Text] [Related]  

  • 12. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer.
    Zhang R; Ru Y; Gao Y; Li J; Mao S
    Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin-loaded polymeric nanoparticles: characterization and potential exploitation for the treatment of non-small cell lung carcinoma.
    Shi C; Yu H; Sun D; Ma L; Tang Z; Xiao Q; Chen X
    Acta Biomater; 2015 May; 18():68-76. PubMed ID: 25707922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy.
    Qu CY; Zhou M; Chen YW; Chen MM; Shen F; Xu LM
    Int J Nanomedicine; 2015; 10():3911-20. PubMed ID: 26089667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
    Singh M; Bhatnagar P; Mishra S; Kumar P; Shukla Y; Gupta KC
    Int J Nanomedicine; 2015; 10():6789-809. PubMed ID: 26586942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy.
    Xu C; Wang Y; Guo Z; Chen J; Lin L; Wu J; Tian H; Chen X
    J Control Release; 2019 Feb; 295():153-163. PubMed ID: 30586598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform.
    Liang Z; Li J; Zhu B
    Drug Des Devel Ther; 2020; 14():4519-4531. PubMed ID: 33149550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
    Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect.
    Fan X; Zhao X; Qu X; Fang J
    Int J Pharm; 2015 Dec; 496(2):644-53. PubMed ID: 26529576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-Drug Nanosystem: Etoposide Prodrug and Cisplatin Coloaded Nanostructured Lipid Carriers for Lung Cancer Therapy.
    Du M; Yin J
    Drug Des Devel Ther; 2022; 16():4139-4149. PubMed ID: 36506793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.